RLI Corp. (NYSE:RLI - Free Report) - Equities researchers at Zacks Research dropped their Q2 2025 EPS estimates for shares of RLI in a research note issued on Monday, May 12th. Zacks Research analyst T. De now forecasts that the insurance provider will post earnings per share of $0.74 for the quarter, down from their prior estimate of $0.82. The consensus estimate for RLI's current full-year earnings is $3.08 per share. Zacks Research also issued estimates for RLI's Q3 2025 earnings at $0.51 EPS, Q4 2025 earnings at $0.77 EPS, FY2025 earnings at $2.95 EPS, Q1 2026 earnings at $0.82 EPS, Q2 2026 earnings at $0.87 EPS, Q3 2026 earnings at $0.57 EPS, Q4 2026 earnings at $0.80 EPS, FY2026 earnings at $3.07 EPS, Q1 2027 earnings at $0.80 EPS and FY2027 earnings at $3.09 EPS.
Several other research firms also recently commented on RLI. StockNews.com upgraded shares of RLI from a "sell" rating to a "hold" rating in a report on Tuesday, May 6th. Jefferies Financial Group downgraded shares of RLI from a "buy" rating to an "underperform" rating and decreased their price objective for the company from $95.00 to $61.00 in a report on Monday, January 27th. Keefe, Bruyette & Woods decreased their price objective on shares of RLI from $95.00 to $85.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. JMP Securities restated a "market perform" rating on shares of RLI in a research note on Thursday, April 24th. Finally, Compass Point downgraded shares of RLI from a "strong-buy" rating to a "hold" rating in a research note on Friday, April 25th. One analyst has rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $78.60.
View Our Latest Research Report on RLI
RLI Stock Up 1.2%
RLI traded up $0.88 during trading on Thursday, reaching $75.71. The company had a trading volume of 251,129 shares, compared to its average volume of 363,796. The business's fifty day moving average price is $76.08 and its 200 day moving average price is $78.83. The company has a debt-to-equity ratio of 0.07, a current ratio of 0.34 and a quick ratio of 0.38. The company has a market cap of $6.95 billion, a P/E ratio of 20.22 and a beta of 0.72. RLI has a 12 month low of $68.50 and a 12 month high of $91.15.
RLI (NYSE:RLI - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The insurance provider reported $0.92 EPS for the quarter, topping the consensus estimate of $0.88 by $0.04. The company had revenue of $36.73 million during the quarter, compared to analysts' expectations of $442.20 million. RLI had a net margin of 19.53% and a return on equity of 16.63%. RLI's revenue was down 8.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.95 EPS.
RLI Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, May 30th will be paid a $0.16 dividend. This is a boost from RLI's previous quarterly dividend of $0.15. This represents a $0.64 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date of this dividend is Friday, May 30th. RLI's payout ratio is currently 21.05%.
Insider Activity at RLI
In related news, Director Robert P. Restrepo, Jr. sold 2,864 shares of the company's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $74.89, for a total transaction of $214,484.96. Following the completion of the transaction, the director now owns 23,312 shares in the company, valued at $1,745,835.68. This represents a 10.94% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jordan W. Graham sold 1,500 shares of the company's stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $74.77, for a total value of $112,155.00. Following the completion of the sale, the director now directly owns 12,854 shares in the company, valued at approximately $961,093.58. The trade was a 10.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.16% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the business. Golden State Wealth Management LLC raised its stake in shares of RLI by 100.0% in the first quarter. Golden State Wealth Management LLC now owns 372 shares of the insurance provider's stock worth $30,000 after buying an additional 186 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in shares of RLI by 100.0% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 396 shares of the insurance provider's stock worth $32,000 after purchasing an additional 198 shares during the period. Versant Capital Management Inc boosted its holdings in shares of RLI by 100.0% in the 1st quarter. Versant Capital Management Inc now owns 406 shares of the insurance provider's stock worth $33,000 after purchasing an additional 203 shares during the period. Farther Finance Advisors LLC lifted its stake in shares of RLI by 88.5% during the 1st quarter. Farther Finance Advisors LLC now owns 477 shares of the insurance provider's stock worth $38,000 after acquiring an additional 224 shares during the last quarter. Finally, Compass Wealth Management LLC lifted its stake in shares of RLI by 100.0% during the 1st quarter. Compass Wealth Management LLC now owns 480 shares of the insurance provider's stock worth $39,000 after acquiring an additional 240 shares during the last quarter. 77.89% of the stock is owned by institutional investors.
RLI Company Profile
(
Get Free Report)
RLI Corp., an insurance holding company, underwrites property and casualty insurance. Its Casualty segment provides commercial and personal coverage products; and general liability products, such as coverage for third-party liability of commercial insureds, including manufacturers, contractors, apartments, and mercantile.
Further Reading

Before you consider RLI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RLI wasn't on the list.
While RLI currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.